Skip to content

Effect of Blue Light Therapy on Recovery After Facial Fracture Surgery

Efficacy of blue light photobiomodulation for post operative healing in operated zygomaticomaxillary complex fractures: A randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112625
Enrollment
30
Registered
2026-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: photobiomodulation group: Experimental group will receive Standard postoperative care + Blue light photobiomodulation after undergoing ORIF under ga for zygomaticomaxillary complex frac
7and 14 Control Intervention1: Without Photobiomodulation group: Control group will receive Standard postoperative care + Sham PBM (device without active emission( placebo effect ) on post op day 1
7 and 14

Sponsors

DR DY PATIL DENTAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with zygomaticomaxillary complex (ZMC) fracture indicated for open reduction and internal fixation (ORIF). Age between 18 and 60 years Medically fit to undergo routine general anesthesia and maxillofacial surgery. Willing to provide informed written consent. Able and willing to attend scheduled postoperative follow-up visits for pain and edema assessment.

Exclusion criteria

Exclusion criteria: Panfacial trauma, or comminuted ZMC fractures. Immuno compromised status or systemic disease that may impair wound healing (e.g., uncontrolled diabetes, collagen vascular disorders). History of epilepsy. Pre-existing facial infection, or skin conditions over the treatment site that may interfere with PBM application. Pregnant or lactating women. Patients with non-compliance risk or inability to follow postoperative instructions.

Design outcomes

Primary

MeasureTime frame
Blue light PBMT is expected to significantly: Reduce postoperative pain levels Decrease facial edema faster Improve patient comfort and recovery Serve as a non-pharmacological, safe adjunct for maxillofacial trauma patients Timepoint: day 1, 3, 5, 7, 14

Secondary

MeasureTime frame
Blue light PBMT is expected to significantly: 1)Reduce postoperative pain levels 2)Decrease facial edema faster 3)Improve patient comfort & recovery 4)Serve as a non-pharmacological, safe adjunct for maxillofacial trauma patients Timepoint: 4TH;6TH AND 10TH DAY

Countries

India

Contacts

Public ContactDr Lakshmi Shetty

dr dy patil dental college and hospital dr dy patil vidyapeeth pimpri pune

drlakshmishetty21@gmail.com9673006494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026